Skip to main content
. 2016 Nov 15;7:434. doi: 10.3389/fphar.2016.00434

FIGURE 5.

FIGURE 5

Tumor tissue of each group at the end of treatment. (A) NS+ NS, (B) HSA (L) + NS, (C) HSA (M) + NS, (D) HSA (H) + NS, (E) NS + DDP, (F) HSA (L) + DDP, (G) HSA (M) + DDP, (H) HSA (H) + DDP, (I) NS + VP-16, (J) HSA (L) + VP-16, (K) HSA (M) + VP-16, (L) HSA (H) + VP-16.